Overview

Welcome to TTRansforming Amyloidosis Care in Kentucky, an initiative to strengthen cardiac amyloidosis care across the state. Funded by a nationally competitive grant, this statewide program is led by UK HealthCare. A Center of Excellence in the management of cardiac amyloidosis (CA), UK’s CA program, directed by Dr. Gaurang Vaidya, is recognized for innovation in the diagnosis, treatment, and research of CA,

Cardiac amyloidosis is a common cause of heart failure but remains under-recognized. In Kentucky alone, over 10,000 patients are estimated to have CA, but only a small fraction of these patients are diagnosed. With highly effective therapies now available for treatment, awareness of cardiac amyloidosis is projected to increase, enabling greater adoption of effective and appropriate screening strategies among providers.

TTRansforming Amyloidosis Care in Kentucky promises to be the state’s most robust, organized, and comprehensive effort dedicated to raising awareness of cardiac amyloidosis among clinicians. To ensure a statewide reach, the following three sites across Kentucky were selected for a CE- accredited dinner presentation: Owensboro, KY; Hazard, KY; and Edgewood, KY.  Each presentation will focus on recognizing and screening high-risk CA patients, understanding novel therapeutic strategies for the treatment of CA, and inculcating an overall culture of CA awareness in the community. Providers involved in the care of CA patients or interested in the disease state are welcome to attend. In addition, opportunities for personal meetings with providers directly at their practice locations are available for those with questions or who wish to engage in deeper discussions about CA diagnosis and treatment.  

Please join us as we take TTRansforming Amyloidosis Care in Kentucky across the region! We hope you will take advantage of the opportunity to connect with colleagues statewide as we collaborate to improve amyloidosis care across the Commonwealth!

Goals and Objectives:

  1. Provide an effective educational program on a statewide platform for the dissemination of information focused on cardiac amyloidosis.
  2. Equip healthcare professionals across Kentucky with information on establishing a local cardiac amyloidosis screening and referral service.
  3. Afford a streamlined referral system for cardiac amyloid patients from communities across Kentucky to a center of excellence within the University of Kentucky.

 

Speakers

Gaurang Vaidya, MD

Assistant Professor
Internal Medicine, Cardiology
University of Kentucky
Lexington, Kentucky View Full Bio

Accreditation

In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME

This live activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

IPE Competencies

  • Roles/ Responsibilities

CPE

This knowledge-based activity will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

CNE

The University of Kentucky, College of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).

This educational activity is offered for a maximum of 1.00 ANCC contact hour.

In order to receive credit, participants complete this CNE activity and submit a credit application and evaluation form online. Certificates may be printed once the evaluation is completed.

Other

UK Healthcare CECentral certifies this activity for 1.00 hour of participation.